Insulin Therapy Center

An interview with Oramed Pharmaceuticals CEO and Principal Investigator about a Phase 2b study of its oral insulin and the latest clinical results.

This approval is an example of artificial intelligence being used to improve the health of our patients with diabetes and will get us closer to a true artificial pancreas.

When hospitals do not employ best practices in glucose control, patients with diabetes experience worse outcomes at greater costs.

A man with type 1 diabetes started an exercise program to help him manage his early morning highs. He exercised every evening, at which time his glucose levels would drop during and after exercise. Thinking that exercise would lower his early morning highs, he did not take his insulin before exercise. He was surprised to see his glucose would go up after exercise rather than go down.

A systematic review to investigate the impact of intrauterine exposure to metformin on neonatal growth vs. insulin

In regards to pharmacotherapy, patients with type 1 diabetes end up solely relying on insulin therapy for their diabetes management: what if there is an add on option?

Rising insulin costs have created limiting barriers in diabetic therapy plans. A recent study provides data on which insulin types may be the most cost-effective.

A new form of insulin working in response to glucose levels.

As the incidence of diabetes increases, insulin use can reasonably be expected to increase, and the mistakes will no doubt increase as well. Insulin is a very powerful medication, and some of these mistakes will require the ambulance, the hospital, or worse.

Data from Randomized Clinical Trial on treating corticosteroid-induced hyperglycemia with the use of NPH insulin protocol therapy.